These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19160313)

  • 1. Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities.
    Thomson A; Maltezos S; Paliokosta E; Xenitidis K
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD007009. PubMed ID: 19160313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities.
    Thomson A; Maltezos S; Paliokosta E; Xenitidis K
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD007011. PubMed ID: 19370667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
    Castells X; Blanco-Silvente L; Cunill R
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Otasowie J; Castells X; Ehimare UP; Smith CH
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006997. PubMed ID: 25238582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
    Verbeeck W; Bekkering GE; Van den Noortgate W; Kramers C
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009504. PubMed ID: 28965364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
    Cortese S; Adamo N; Del Giovane C; Mohr-Jensen C; Hayes AJ; Carucci S; Atkinson LZ; Tessari L; Banaschewski T; Coghill D; Hollis C; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A
    Lancet Psychiatry; 2018 Sep; 5(9):727-738. PubMed ID: 30097390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
    Cortese S; Adamo N; Mohr-Jensen C; Hayes AJ; Bhatti S; Carucci S; Del Giovane C; Atkinson LZ; Banaschewski T; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A; Coghill D;
    BMJ Open; 2017 Jan; 7(1):e013967. PubMed ID: 28073796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Punja S; Shamseer L; Hartling L; Urichuk L; Vandermeer B; Nikles J; Vohra S
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009996. PubMed ID: 26844979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options.
    Hodgkins P; Shaw M; Coghill D; Hechtman L
    Eur Child Adolesc Psychiatry; 2012 Sep; 21(9):477-92. PubMed ID: 22763750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
    Pringsheim T; Steeves T
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.
    Wu EQ; Hodgkins P; Ben-Hamadi R; Setyawan J; Xie J; Sikirica V; Du EX; Yan SY; Erder MH
    CNS Drugs; 2012 Jul; 26(7):581-600. PubMed ID: 22712698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis.
    Stuhec M; Lukić P; Locatelli I
    Ann Pharmacother; 2019 Feb; 53(2):121-133. PubMed ID: 30117329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of methylphenidate in the management of Attention Deficit Hyperactivity Disorder (ADHD) in people with intellectual disabilities: A systematic review.
    Tarrant N; Roy M; Deb S; Odedra S; Retzer A; Roy A
    Res Dev Disabil; 2018 Dec; 83():217-232. PubMed ID: 30266025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of methylphenidate for attention-deficit/hyperactivity disorder in children with borderline intellectual functioning or intellectual disability: A systematic review and meta-analysis.
    Sun CK; Tseng PT; Wu CK; Li DJ; Chen TY; Stubbs B; Carvalho AF; Chen YW; Lin PY; Cheng YS; Wu MK
    Sci Rep; 2019 Nov; 9(1):15908. PubMed ID: 31685858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis.
    Faraone SV; Buitelaar J
    Eur Child Adolesc Psychiatry; 2010 Apr; 19(4):353-64. PubMed ID: 19763664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.